bxl017

Bo Lu, MD

Contact Dr. Lu

G-301 Bodine Cancer Center
111 S. 11th Street
Philadelphia, PA 19107

(215) 955-6705
(215) 503-0013 fax

Most Recent Peer-reviewed Publications

  1. Targeting Myeloid-derived Suppressor Cells and Programmed Death Ligand 1 Confers Therapeutic Advantage of Ablative Hypofractionated Radiation Therapy Compared With Conventional Fractionated Radiation Therapy
  2. Blockade of Tumor-Expressed PD-1 promotes lung cancer growth
  3. PD-1 Modulates Radiation-Induced Cardiac Toxicity through Cytotoxic T Lymphocytes
  4. Utility of stereotactic ablative radiotherapy/stereotactic body radiation therapy in the setting of oligometastatic non-small cell lung cancer
  5. Decreased Survival After Combining Thoracic Irradiation and an Anti-PD-1 Antibody Correlated With Increased T-cell Infiltration Into Cardiac and Lung Tissues
  6. A universal parameterized gradient-based method for photon beam field size determination
  7. IGFBP3 modulates lung tumorigenesis and cell growth through IGF1 signaling
  8. Angular under-sampling effect on VMAT dose calculation: An analysis and a solution strategy
  9. Image-Guided High-Dose Rate Brachytherapy in Cervix Carcinoma Using Balloon Catheter and Belt Immobilization System
  10. Comparison of Online 6 Degree-of-Freedom Image Registration of Varian TrueBeam Cone-Beam CT and BrainLab ExacTrac X-Ray for Intracranial Radiosurgery
  11. Neutrophil to lymphocyte ratio associated with prognosis of lung cancer
  12. Treatment Design and Rationale for a Randomized Trial of Cisplatin and Etoposide Plus Thoracic Radiotherapy Followed by Nivolumab or Placebo for Locally Advanced Non–Small-Cell Lung Cancer (RTOG 3505)
  13. siRNA-Encapsulated Hybrid Nanoparticles Target Mutant K-ras and Inhibit Metastatic Tumor Burden in a Mouse Model of Lung Cancer
  14. Brigatinib and the new generation of ALK-inhibitors for non-small cell lung cancer
  15. Efficient independent planar dose calculation for FFF IMRT QA with a bivariate Gaussian source model
  16. Debio-1143: Inhibitor of apoptosis protein (IAP) antagonist Cancer therapy
  17. Comparison between proton boron fusion therapy (PBFT) and boron neutron capture therapy (BNCT): A monte carlo study
  18. Stereotactic Body Radiation Therapy Delivery in a Genetically Engineered Mouse Model of Lung Cancer
  19. Immune biomarkers of treatment failure for a patient on a phase i clinical trial of pembrolizumab plus radiotherapy
  20. The investigation of physical conditions of boron uptake region in proton boron fusion therapy (PBFT)